| Patient | Ernest Shackleton |
|---|---|
| Date of birth | 1979-02-15 |
| Identifiers | MRN HR-EX001-SYN; SSN (made up) 000-01-7763 |
| Document date | 2026-05-12 |
| Author | Cormac Ellingsworth-Daly, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient visit for chest tightness and breathlessness on exertion in a heavy smoker planning a polar expedition: risk assessment, ECG and blood tests, starting treatment, smoking and alcohol counseling, and a cardiology referral [S]
This fictional modern episode addresses the presenting concerns below. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
5 later historical claims are omitted because they describe events after the index age. See the teaching note.
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1903 | Breathlessness and weakness that stopped him pulling a sledge on a polar journey in his late twenties, attributed at the time to scurvy and asthma; sent home | D (CLM-0002) |
| January 20, 1908 | Very unwell after heavy hauling on a rope on a polar expedition in his thirties; a pulmonary systolic murmur heard twice by the expedition doctor | D (CLM-0003) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release tablet, one tablet by mouth daily | once daily | Oral route | 2026-05-12 | active | S |
| Atorvastatin 80 mg tablet, one tablet by mouth daily | once daily | Oral route | 2026-05-12 | active | S |
| Metoprolol succinate extended-release 50 mg tablet, one tablet by mouth daily | once daily | Oral route | 2026-05-12 to 2026-05-26 | stopped | S |
| Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue for chest pain, repeat every 5 minutes up to 3 doses | as needed for chest pain, up to 3 doses | Sublingual route | 2026-05-12 | active | S |
| Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titration | twice a day after titration | Oral route | 2026-05-12 | active | S |
Positive for the concerns in the history of present illness. Alert, warm, and forceful; optimistic and impatient with delay; PHQ-2 score 1. No other systems reported as affected in this synthetic episode. [S]
Alert and engaged. Independent; stops on the second flight of stairs or after carrying a crate a short distance until the tightness passes. [S]
Vital signs recorded on 2026-05-12; see the Vital Signs section. Mental status: Alert, warm, and forceful; optimistic and impatient with delay; PHQ-2 score 1. The physical examination is limited to the findings relevant to this synthetic episode. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-12 | Body height | 175 | cm | S |
| 2026-05-12 | Body weight | 86 | kg | S |
| 2026-05-12 | Body mass index (BMI) [Ratio] | 28.1 | kg/m2 | S |
| 2026-05-12 | Systolic blood pressure | 138 | mm[Hg] | S |
| 2026-05-12 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 2026-05-12 | Heart rate | 78 | /min | S |
| 2026-05-12 | Respiratory rate | 16 | /min | S |
| 2026-05-12 | Body temperature | 36.7 | Cel | S |
| 2026-05-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-05-12 | Cholesterol [Mass/volume] in Serum or Plasma | 246 | mg/dL | <=199 mg/dL | High | S |
| 2026-05-12 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 38 | mg/dL | >=40 mg/dL | Low | S |
| 2026-05-12 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 168 | mg/dL | Below 100 for the general population; below 55 is his treatment target | High | S |
| 2026-05-12 | Triglyceride [Mass/volume] in Serum or Plasma | 200 | mg/dL | <=149 mg/dL | High | S |
| 2026-05-12 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.9 | % | <=5.6% | High | S |
| 2026-05-12 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-05-12 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-05-12 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 41 | U/L | 7-52 U/L | Normal | S |
| 2026-05-12 | Hemoglobin [Mass/volume] in Blood | 15.8 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 2026-05-12 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-05-12 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 96 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 2026-05-12 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-05-12 | Total score [AUDIT] | 12 | {score} | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Chest tightness and breathlessness on exertion for about three months, brought on by stairs, carrying loads, and walking fast in cold wind and relieved within minutes by rest, never at rest; resting ECG normal; cause not yet established at intake; coronary CT angiography and cardiology consultation requested | active | confirmed | R07.89 | S — Synthetic presenting problem anchored to his documented exertional breathlessness; superseded by the diagnosis at the cardiology consultation. |
| Nicotine dependence, cigarettes: about 25 a day since 16 (about 39 pack-years) | active | confirmed | F17.210 | S — Synthetic modern coding anchored to his documented heavy smoking. |
| Hyperlipidemia: LDL cholesterol 168 mg/dL and HDL 38 mg/dL at intake | active | confirmed | E78.5 | S — Synthetic modern risk factor; no historical measurement exists. |
| Prediabetes: HbA1c 5.9% at intake | active | confirmed | R73.03 | S — Synthetic modern risk factor; no historical measurement exists. |